Aarti Pharmalabs Limited (NSE:AARTIPHARM)

India flag India · Delayed Price · Currency is INR
700.15
+1.30 (0.19%)
At close: Mar 6, 2026
-7.74%
Market Cap 63.47B
Revenue (ttm) 18.01B
Net Income (ttm) 2.14B
Shares Out 90.66M
EPS (ttm) 23.56
PE Ratio 29.72
Forward PE n/a
Dividend 5.00 (0.72%)
Ex-Dividend Date Feb 16, 2026
Volume 96,779
Average Volume 196,790
Open 701.75
Previous Close 698.85
Day's Range 688.50 - 707.90
52-Week Range 574.45 - 971.00
Beta -0.40
RSI 43.62
Earnings Date Feb 9, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con... [Read more]

Sector Healthcare
Founded 2019
Employees 2,162
Stock Exchange National Stock Exchange of India
Ticker Symbol AARTIPHARM
Full Company Profile

Financial Performance

In fiscal year 2025, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.

Financial Statements

News

There is no news available yet.